Korean Chinese Japanese
  • Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Korean Chinese Japanese
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Corporation
Lifestyle

Vaxcell-Bio Therapeutics: Why It Filed for a ‘Clinical Trial’ Despite Risk Adjustments for VCB-1102

Vaxcell-Bio Therapeutics(323990)is launching additional clinical trials, including a controlled study, to enter the market for the treatment of advanced liver cancer with its core pipeline product, th…
  • 2026-09-29 08:16:02
  • Kim Jinsoo
Lifestyle

PROTEINA CO., LTD. Benefits from AI-Driven New Drug Development… Ingenia Highlights the Technological Value of Its Global Phase 3 Trial [Bio Spotlight]

On the 23rd, the domestic pharmaceutical and life sciences sectors showed mixed trends. The life sciences sector rose 0.64%. Of the 92 stocks in the sector, 53 rose, 8 remained unchanged, and 31 fell,…
  • 2026-09-29 07:31:02
  • KIM JI-WAN
Electronics

"Fall Behind in Investment, and You'll Be Left Behind"... Korea, China, Japan, and Germany Battle It Out for the 'Dream Battery' [only-EDAILY]

“If you fall behind in investing, you could easily be left behind.”The fact that South Korea’s three major battery manufacturers have successively disclosed patents related to all-solid-state batterie…
  • 2026-09-29 05:00:07
  • JAEMIN SONG
Electronics

A Flurry of South Korean 'All-Solid-State Battery Patents'... Cars Powered by the 'Dream Battery' to Hit the Roads Next Year [only-EDAILY]

All-solid-state batteries, often referred to as the “dream battery,” are moving beyond research and development (R&D) into the arena of commercialization competition. This month, South Korea’s three m…
  • 2026-09-29 05:00:07
  • JAEMIN SONG
Lifestyle

Kim Seong-yeon, Largest Shareholder of OSCOTEC Inc., Joins Forces with Second-Largest Shareholder to Restructure the Board of Directors

Kim Seong-yeon, a director at Genosco and the only son and largest shareholder of Kim Jeong-geun, the former founder of OSCOTEC Inc.(039200), is moving to restructure the board of directors to gain a …
  • 2026-09-28 21:32:02
  • Kim Jinsoo
Electronics

SamsungElectronics DX Union Elects New Chair… Pushes for Increased Compensation and Joint Bargaining

“SamsungElectronics Labor Union Donghaeng,” a labor union centered on employees of SamsungElectronics’ Consumer Electronics (DX) Division, has elected Son Yong-ho as its new chairman. The new executiv…
  • 2026-09-28 17:31:37
  • JAEMIN SONG
Electronics

SK hynix Conducts HBM5 Validation with TSMC… Named “Partner of the Year” for the Second Consecutive Year

SK hynix has been named “Partner of the Year” for the second consecutive year in recognition of its successful joint validation of HBM5—the next-generation high-bandwidth memory (HBM)—with Taiwan’s TS…
  • 2026-09-28 16:40:15
  • JAEMIN SONG
Lifestyle

Contract Worker Killed in Pinch Accident at OTOKI Affiliate Factory

A contract worker in his 40s died while receiving treatment after being caught in a product loading machine at a factory operated by OTOKI SF, an affiliate of Ottogi(007310). OTOKI CI. (Photo court…
  • 2026-09-28 16:14:32
  • Kim Ji-woo
Electronics

Home Appliance Subscription Revenue Nears 1 Trillion… SamsungElectronics Expands into the B2B Market

SamsungElectronics is completely revamping its home appliance subscription service to mark the second anniversary of its launch. The company is expanding its reach by introducing services targeting ne…
  • 2026-09-28 15:47:11
  • Choi Oh-hyun
Lifestyle

SCL Science Partners with Thailand’s Meditop Inc. to Expand Hemostatic Agent Business into Southeast Asia

SCL Science(246960)is pursuing entry into the Thai market with its absorbable hemostatic agent, InnoSEAL Plus DL. MOU signing ceremony between companies for the “Thailand Market Development Mission…
  • 2026-09-28 13:48:02
  • KIM JI-WAN
1 2 3 4 5 6 7 8 9 10 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea China Japan
English